{ }
001122334455554433221100
001122334455554433221100

Jim Cramer recommends buying Stryker Corp and holding long term

Jim Cramer has recommended Stryker Corp (SYK) as a buy, advising investors to adopt a long-term perspective and "forget about it." This suggests confidence in the company's future performance and stability in the market.

Top Health Care Stocks to Consider for Investment in 2025

Amgen's MariTide obesity drug showed mid-stage trial results in line with competitors, while Stryker's Mako robotic product and outpatient focus position it as a strong investment. Pfizer's potential divestment of its hospital drugs business could enhance its core growth, and Boston Scientific's promising pipeline supports its long-term outlook. CFRA maintains "buy" ratings for these companies, with specific price targets reflecting their growth potential.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.